Search
SWG Committee
Current committee members
Konstanze Döhner, Germany (Chair)
Dominique Bonnet, France (Vice-Chair)
Immacolata Andolfo, Italy
Igor Aurer, Croatia
Alessandro Casini, Italy
Hermann Einsele, Germany
Eleni Gavriilaki, Greece (YoungEHA representative)
Kirsten Grønbæk, Denmark (Councilor)
Zoi Dorothea Pana, Cyprus
Marc Raaijmakers, The Netherlands
Josef Vormoor, The Netherlands
Aim
The SWG Committee is the coordinating body of…
SWG Educational Activities
MeetingsEHA SWG EWALL SymposiumLocation and dateThis meeting was held in Frankfurt in June 2023 as part of EHA2023. TopicPersonalized ALL therapy. ChairNicola Gokbuget
Sessions and speakers
B-cell precursor ALL, the Finnish experience (Kimmo Porkka).
Deadlines & Announcements
New announcements will be published as soon as new elements for the Congress Sponsor Program for EHA2025 are released.
Read moreDates and deadlines
You may find in this page all the dates and deadlines related to the EHA2024 Hybrid Congress. All deadlines, except if mentioned differently, end at 23:59 CET/CEST.
The timelines will be updated regularly.
Guidelines Committee
Current committee members
Noémi Roy, United Kingdom (Chair)
Martin Dreyling, Germany (Vice-Chair)
Steffen Koschmieder, Germany (Executive member)
Marieke Kruip, The Netherlands (Executive member)
Associate members
Tamam Bakchoul, Germany
Sabine Blum, Switzerland
Cristina Castilla Llorente, France
Lydie Da Costa, France
Carlo Dufour, Italy
Wojciech Jurczak, Poland
Simon Stanworth, United Kingdom
AimThe aim of the…
Evaluation of 243 patients with deletion 17p chronic lymphocytic leukemia treated with ibrutinib: a cross-study analysis of treatment outcomes
Evaluation of 243 patients with deletion 17p chronic lymphocytic leukemia treated with ibrutinib: a cross-study analysis of treatment outcomes
Chronic lymphocytic leukemia (CLL) with the deletion of chromosome 17p (del17p) has been linked to aggressive disease and patient survival of only…
Preanalytical WG
Responsibilities:
Reviewing SOPs for sample handling and storage to ensure uniformity across the consortium. Overseeing the logistics of sample collection. Defining the minimum (core markers) and extended panels for immunophenotyping. Establishing good practice sampling for retrospective analysis.
- «
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- »